Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Adiana Inc.

This article was originally published in Start Up

Executive Summary

Adiana aims to improve the most popular method of female sterilization--tubal ligation--with a device that can be used in a doctor's office, to perform the procedure less invasively. A catheter guided through the vagina on up into the fallopian tubes will give a short dose of radiofrequency to ablate the cells lining the tube, and a small spongy matrix will be left behind. The energy-induced injury will prompt tissue ingrowth into the matrix, so that healthy tissue will permanently block the tubes.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts